← All Sponsors
SPONSOR

Jaehoon Ko

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: COVID-19
NCT06159283 Phase 2
Recruiting

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

COVID-19
South Korea View Trial →